1. Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study†. (16th May 2014) Authors: Grothey, Axel; Flick, E. Dawn; Cohn, Allen L.; Bekaii‐Saab, Tanios S.; Bendell, Johanna C.; Kozloff, Mark; Roach, Nancy; Mun, Yong; Fish, Susan; Hurwitz, Herbert I. Journal: Pharmacoepidemiology and drug safety Issue: Volume 23:Number 7(2014:Jul.) Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effectiveness of bevacizumab exposure beyond disease progression in patients with non–small‐cell lung cancer: analyses of the ARIES observational cohort study†. Issue 5 (8th January 2016) Authors: Leon, Larry; Kosty, Michael; Jahanzeb, Mohammad; Spigel, David; Wozniak, Antoinette J.; Brahmer, Julie; Fish, Susan; Flick, E. Dawn; Hazard, Sebastien J.; Lynch, Thomas J. Journal: Pharmacoepidemiology and drug safety Issue: Volume 25:Issue 5(2016) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Therapeutic activity of an interleukin‐4/interleukin‐13 dual antagonist on oxazolone‐induced colitis in mice. Issue 3 (November 2014) Authors: Kasaian, Marion T.; Page, Karen M.; Fish, Susan; Brennan, Agnes; Cook, Timothy A.; Moreira, Karen; Zhang, Melvin; Jesson, Michael; Marquette, Kimberly; Agostinelli, Rita; Lee, Julie; Williams, Cara M. M.; Tchistiakova, Lioudmila; Thakker, Paresh Journal: Immunology Issue: Volume 143:Issue 3(2014:Nov.) Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗